SCHEMBL25818816

SCHEMBL25818816

Cc1ccc2c(c1)CN(CCN(C)C)C2

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP8 Q6V1X1 2/20 0.38
DPP9 Q86TI2 2/20 0.38
DPP7 Q9UHL4 1/20 0.38
KCNH2 Q12809 4/20 0.36
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
PTK2B Q14289 1/20 0.35
ESR2 Q92731 1/20 0.35
METAP1 P53582 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP2D6 P10635 5/20 0.34
HRH1 P35367 3/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25818517 0.87 MEN1 (0.45) ALDH1A1KDM4ELMNAMAPTPTK2B
SCHEMBL15206662 0.81 SIGMAR1 (0.41) ALDH1A1KDM4ELMNAMAPTPTK2B
SCHEMBL23010793 0.81 BRD4 (0.40) ALDH1A1HRH1
SCHEMBL22993028 0.80 ALDH1A1 (0.44) DPP8DPP9DPP7KCNH2ALDH1A1
SCHEMBL24109988 0.79 HTR2C (0.48) SLC6A2SLC6A4SLC6A3
SCHEMBL17409800 0.76 POLB (0.42) DPP8DPP9DPP7KCNH2ALDH1A1
SCHEMBL13961198 0.76 DPP8 (0.45) DPP8DPP9DPP7KCNH2ALDH1A1
SCHEMBL29606020 0.75 SIGMAR1 (0.47) DPP7KDM4EMAPT
SCHEMBL18664437 0.73 DPP8 (0.45) DPP8DPP9DPP7KDM4EMEN1
SCHEMBL2835665 0.73 SLC6A2 (0.49) DPP8DPP9DPP7KCNH2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF GAP43, SLC18A2, PNMT DPP8 3072/4885DPP9 4024/4885DPP7 2767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.